LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of ...

Former President Trump has claimed he, and not President Biden or Vice President Harris, was responsible for capping the price of insulin at $35 a month. While the Trump administration implemented a ...

In what’s being heralded as a potentially revolutionary solution for diabetics, scientists have developed a type of insulin that can respond to changing blood sugar levels in real-time.

A weekly insulin injection will soon become available in Canada, which doctors say will “make life easier” for people living with diabetes and is an “exciting” treatment to have in the toolbox.

President Joe Biden is campaigning on his success in getting seniors with diabetes a $35-per-month cap on their insulin spending. But his Republican opponent, former President Donald Trump, claimed ...

WASHINGTON — Both President Biden and former President Trump love to claim credit for getting more Americans $35 insulin. But the credit should actually go to a giant pharmaceutical company — just the ...

Diabetes rates continue to rise. Scientists have now created a pain-free drug delivery method to help people with diabetes manage the disease and maintain their health more easily. Researchers have ...

Around 8 million people in the United States rely on insulin to manage their diabetes, but steady price increases have made the life-saving medicine increasingly more difficult to afford. As many as ...

After she was diagnosed at age 48 with Type 1 diabetes, Stacey Silverman muddled through her days with high blood sugar, fatigue and splitting headaches. Taking a long-acting form of insulin called ...

Diabetics will now see a break in their out-of-pocket costs for insulin. Sanofi, one of the leading manufacturers of the hormone, joined two other major pharmaceutical companies in capping their ...

Researchers have taken a big step forward in the quest to regenerate the pancreatic beta-cells damaged by type 1 diabetes. Using FDA-approved drugs usually given to patients with rare cancers, they ...